Gut microbiota: A novel target for sepsis treatment
Saved in:
| Main Authors: | Weifeng Shang, Sheng Zhang, Lechen Yang, Jiao Liu, Dechang Chen, Jing Ni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2025-07-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003630 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identifying propionate metabolism-related genes as biomarkers of sepsis development and therapeutic targets
by: Lechen Yang, et al.
Published: (2025-07-01) -
Gut microbiota and sepsis-associated encephalopathy: pathogenesis and precision therapies
by: Na Wei, et al.
Published: (2025-07-01) -
Gut microbiota-derived imidazole propionate: an emerging target for the prevention and treatment of cardiometabolic diseases
by: Yan Zeng, et al.
Published: (2025-02-01) -
Targeting gut microbiota for diabetic nephropathy treatment: probiotics, dietary interventions, and fecal microbiota transplantation
by: Xiaoran Wang, et al.
Published: (2025-06-01) -
New targets for the treatment of ulcerative colitis: Gut microbiota and its metabolites
by: Huanyu Li, et al.
Published: (2025-01-01)